Cordavis is a new subsidiary from CVS Health Corporation that will work with manufacturers to commercialize and coproduce biosimilars, beginning with an adalimumab product.This article originally appeared on The Center for Biosimilars®, a sister site of The American Journal of Managed Care®.CVS Health Corporation announced that it is launching a new subsidiary (Cordavis), which will […]
